Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10392421 Cytotoxic peptides and conjugates thereof

Patent 10392421 was granted and assigned to Novartis on August, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Novartis

Current Assignee

Novartis

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103924210

Patent Inventor Names

Weijia Ou0

Yunho Jin0

Yongqin Wan0

Bernhard Hubert Geierstanger0

Jan Grunewald0

Tetsuo Uno0

Xing Wang0

Date of Patent

August 27, 2019

Patent Application Number

159615310

Date Filed

April 24, 2018

Patent Citations Received

‌

US Patent 11596695 Specific sites for modifying antibodies to make immunoconjugates

Patent Primary Examiner

‌

Kaipeen E Yang

Patent abstract

Disclosed herein are novel cytotoxic peptides of formula (I) as described herein:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10392421 Cytotoxic peptides and conjugates thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API